Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Study Investigators (U01)

The summary for the Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Study Investigators (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Study Investigators (U01): -Purpose. The purpose of this funding opportunity is to support genome-wide association (GWA) studies in randomized controlled clinical trials to identify genetic variants associated with response to treatments for conditions of clinical or public health significance. -Mechanism of Support. This FOA will utilize the U01 Cooperative Agreement grant mechanism. -Funds Available and Anticipated Number of Awards. The total amount of funding to be awarded through this FOA is $8.8 million; it is anticipated that 3-5 awards will be made under this announcement. Applicants should NOT include costs for genome-wide genotyping in their applications; these will be supported separately by NHGRI.

Federal Grant Title:	Genome-wide Association Studies of Treatment Response in Randomized Clinical Trials - Study Investigators (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HG-08-004
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.172
CFDA Descriptions:	Human Genome Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Nov 13, 2008
Posted Date:	Aug 19, 2008
Creation Date:	Aug 19, 2008
Archive Date:	Dec 14, 2008
Total Program Funding:	$2,300,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) State governments Private institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed); • SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional); • STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional); • Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optio...; • Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial R...; • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...; • Cellular Models of HIV Pathogenesis within NIDDK Mission Areas (R01 Clinical Trial Not All...; • U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 C...; • Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Option...; • Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)